Antimicrobial dressings for the prevention of catheter-related infections in newborn infants with central venous catheters

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 3, 2016, Pages

  Lai, Nai Ming ^a,b   Taylor, Jacqueline E ^c   Tan, Kenneth ^d   Choo, Yao Mun ^a   Ahmad Kamar, Azanna ^a   Muhamad, Nor Asiah ^e  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b TAYLOR S UNIVERSITY   (Malaysia)

^c MONASH MEDICAL CENTRE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTIINFECTIVE AGENT; CHLORHEXIDINE GLUCONATE; POVIDONE IODINE; SILVER ALGINATE; UNCLASSIFIED DRUG; ALCOHOL; CHLORHEXIDINE; GLUCURONIC ACID; HEXURONIC ACID; POLYURETHAN; SILVER DERIVATIVE;

ALLERGIC REACTION; ANAPHYLAXIS; ANTISEPSIS; APPLICATION SITE INFECTION; BANDAGES AND DRESSINGS; BAYLEY SCALES OF INFANT DEVELOPMENT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHLORHEXIDINE DRESSING; CONTACT DERMATITIS; DRUG EFFICACY; DRUG SAFETY; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; MICROBIAL COLONIZATION; NECROSIS; NEWBORN; OUTCOME ASSESSMENT; POLYURETHANE DRESSING; REVIEW; SKIN IRRITATION; SYSTEMATIC REVIEW; ADVERSE EFFECTS; BANDAGE; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; DERMATITIS, CONTACT; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ALGINATES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BANDAGES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CENTRAL VENOUS CATHETERS; CHLORHEXIDINE; DERMATITIS, CONTACT; ETHANOL; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; INFANT, NEWBORN; POLYURETHANES; POVIDONE-IODINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SILVER COMPOUNDS;

EID: 84961879797     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011082.pub2     Document Type: Review

References (100)

1. Garland JS, Alex CP, Mueller CD, Cisler-Kahill LA. Local reactions to a chlorhexidine gluconate-impregnated antimicrobial dressing in very low birth weight infants. Pediatric Infectious Disease Journal 1996;15(10):912-4.
2. Garland JS, Alex CP, Mueller CD, Otten D, Shivpuri C, Harris MC, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107(6):1431-6.
3. Hill ML, Baldwin L, Slaughter JC, Walsh WF, Weitkamp JH. A silver-alginate-coated dressing to reduce peripherally inserted central catheter (PICC) infections in NICU patients: a pilot randomized controlled trial. Journal of Perinatology 2010;30(7):469-73.
4. Khattak AZ, Ross R, Ngo T, Shoemaker CT. A randomized controlled evaluation of absorption of silver with the use of silver alginate (Algidex) patches in very low birth weight (VLBW) infants with central lines. Journal of Perinatology 2010;30(5):337-42.
5. Bertini G, Elia S, Ceciarini F, Dani C. Reduction of catheter-related bloodstream infections in preterm infants by the use of catheters with the AgION antimicrobial system. Early Human Development 2013;89(1):21-5.
6. Brito CS, Marques Ribas R, Resende DS, Von Dolinger de Brito D, Abdallah VO, dos Santos KR, et al. Genotypic study documents divergence in the pathogenesis of bloodstream infection related central venous catheters in neonates. Brazilian Journal of Infectious Diseases 2014;18(4):387-93.
7. Brooker RW, Keenan WJ. Catheter related bloodstream infection following PICC removal in preterm infants. Journal of Perinatology 2007;27(3):171-4.
8. Casner M, Hoesli SJ, Slaughter JC, Hill M, Weitkamp JH. Incidence of catheter-related bloodstream infections in neonates following removal of peripherally inserted central venous catheters. Pediatric Critical Care Medicine 2014;15(1):42-8.
9. Cox EG, Knoderer CA, Jennings A, Brown JW, Rodefeld MD, Walker SG, et al. A randomized, controlled trial of catheter-related infectious event rates using antibiotic-impregnated catheters versus conventional catheters in pediatric cardiovascular surgery patients. Journal of the Pediatric Infectious Diseases Society 2013;2(1):67-70.
10. Dawson S, Fitzgerald P, Langer JC, Walton M, Winthrop A, Lau G, et al. A preoperative protocol for the prevention of infection in children with tunnelled right atrial catheters. Oncology Reports 2000;7(6):1239-42.
11. Fallat ME, Gallinaro RN, Stover BH, Wilkerson S, Goldsmith LJ. Central venous catheter bloodstream infections in the neonatal intensive care unit. Journal of Pediatric Surgery 1998;33(9):1383-7.
12. Fanos V, Dall'Agnola A. Antibiotics in neonatal infections: a review. Drugs 1999;58(3):405-27.
13. Filippi L, Pezzati M, Di Amario S, Poggi C, Pecile P. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial. Pediatric Critical Care Medicine 2007;8(6):556-62.
14. Garcia-Teresa MA, Casado-Flores J, Delgado Dominguez M A, Roqueta-Mas J, Cambra-Lasaosa F, Concha-Torre A, et al. Infectious complications of percutaneous central venous catheterization in pediatric patients: a Spanish multicenter study. Intensive Care Medicine 2007;33(3):466-76.
15. Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial. Pediatrics 2005;116(2):e198-205.
16. Garland JS, Alex CP, Sevallius JM, Murphy DM, Good MJ, Volberding AM, et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infection Control and Hospital Epidemiology 2008;29(3):243-9.
17. Garland JS, Alex CP, Uhing MR, Peterside IE, Rentz A, Harris MC. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. Journal of Perinatology 2009;29(12):808-13.
18. Gilad J, Borer A. Prevention of catheter-related bloodstream infections in the neonatal intensive care setting. Expert Review of Anti-Infective Therapy 2006;4(5):861-73.
19. Gilbert RE, Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Current Opinion in Infectious Diseases 2008;21(3):235-45.
20. Golombek SG, Rohan AJ, Parvez B, Salice AL, LaGamma EF. "Proactive" management of percutaneously inserted central catheters results in decreased incidence of infection in the ELBW population. Journal of Perinatology 2002;22(3):209-13.
21. Gravel D, Matlow A, Ofner-Agostini M, Loeb M, Johnston L, Bryce E, et al. A point prevalence survey of health care-associated infections in pediatric populations in major Canadian acute care hospitals. American Journal of Infection Control 2007;35(3):157-62.
22. Grigor'ev VE, Pankova VP. Prevention of suppurative-inflammatory complications in catheterization of central veins. Anesteziologiia i Reanimatologiia 1993;2(2):63-4.
23. Handrup MM, Fuursted K, Funch P, Moller JK, Schroder H. Biofilm formation in long-term central venous catheters in children with cancer: A randomized controlled open-labelled trial of taurolidine versus heparin. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 2012;120(10):794-801.
24. Harms K, Herting E, Kron M, Schiffmann H, Schulz-Ehlbeck H. Randomized, controlled trial of amoxicillin prophylaxis for prevention of catheter-related infections in newborn infants with central venous silicone elastomer catheters. Journal of Pediatrics 1995;127(4):615-9.
25. Hei MY, Zhang XC, Gao XY, Zhao LL, Wu ZX, Tian L, et al. Catheter-related infection and pathogens of umbilical venous catheterization in a neonatal intensive care unit in China. American Journal of Perinatology 2012;29(2):107-14.
26. Helder O, Van Den Hoogen A, De Boer C, Van Goudoever J, Verboon-Maciolek M, Kornelisse R. Non pharmacological interventions to reduce bloodstream infections in infants admitted to a neonatal intensive care unit. Intensive Care Medicine 2013;39:S6.
27. Hemels MA, van den Hoogen A, Verboon-Maciolek MA, Fleer A, Krediet TG. Prevention of neonatal late-onset sepsis associated with the removal of percutaneously inserted central venous catheters in preterm infants. Pediatric Critical Care Medicine 2011;12(4):445-8.
28. Huang YC, Lien RI, Su LH, Chou YH, Lin TY. Successful control of methicillin-resistant Staphylococcus aureus in endemic neonatal intensive care units-A 7-year campaign. PLoS ONE 2011;6(8):e23001.
29. Hussain S, Gomez MM, Wludyka P, Chiu T, Rathore MH. Survival times and complications of catheters used for outpatient parenteral antibiotic therapy in children. Clinical Pediatrics 2007;46(3):247-51.
30. Inglis GD, Davies MW. Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical venous catheters. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD005251.pub2]
31. Kellam B, Fraze DE, Kanarek KS. Central line dressing material and neonatal skin integrity. Nutrition in Clinical Practice 1988;3(2):65-8.
32. Larsen LN, Malchau E, Kristensen B, Schroeder H. Hydrochloric acid treatment of tunneled central venous catheter infections in children with cancer. Journal of Pediatric Hematology/oncology 2011;33(2):e64-8.
33. Lee OK, Johnston L. A systematic review for effective management of central venous catheters and catheter sites in acute care paediatric patients. Worldviews on Evidence-based Nursing / Sigma Theta Tau International, Honor Society of Nursing 2005;2(1):4-13; discussion 14-5.
34. Leibovitz E, Iuster-Reicher A, Amitai M, Mogilner B. Systemic candidal infections associated with use of peripheral venous catheters in neonates: A 9-year experience. Clinical Infectious Diseases 1992;14(2):485-91.
35. Li S, Bizzarro MJ. Prevention of central line associated bloodstream infections in critical care units. Current Opinion in Pediatrics 2011;23(1):85-90.
36. Machado AF, Pedreira ML, Chaud MN. Prospective, randomized and controlled trial on the dwell time of peripheral intravenous catheters in children, according to three dressing regimens. Revista Latino-Americana Enfermagem 2005;13(3):291-8.
37. Mahieu LM, De Dooy JJ, Lenaerts AE, Ieven MM, De Muynck AO. Catheter manipulations and the risk of catheter-associated bloodstream infection in neonatal intensive care unit patients. Journal of Hospital Infection 2001;48(1):20-6.
38. Millar M, Zhou W, Skinner R, Pizer B, Hennessy E, Wilks M, et al. Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer. Health Technology Assessment 2011;15(7):1-114.
39. Quach C, Milstone AM, Perpete C, Bonenfant M, Moore DL, Perreault T. Chlorhexidine bathing in a tertiary care neonatal intensive care unit: Impact on central line-associated bloodstream infections. Infection Control and Hospital Epidemiology 2014;35(2):158-63.
40. Ragavan M, Gazula S, Yadav DK, Agarwala S, Srinivas M, Bajpai M, et al. Peripherally inserted central venous lines versus central lines in surgical newborns - A comparison. Indian Journal of Pediatrics 2010;77(2):171-4.
41. Sannoh S, Clones B, Munoz J, Montecalvo M, Parvez B. A multimodal approach to central venous catheter hub care can decrease catheter-related bloodstream infection. American Journal of Infection Control 2010;38(6):424-9.
42. Seliem W, Abdel-Hady H, El-Nady G. Amikacin-heparin lock for prevention of catheter-related bloodstream infection in neonates with extended umbilical venous catheters use: A randomized controlled trial. Journal of Neonatal-Perinatal Medicine 2010;3(1):33-41.
43. Shapey IM, Foster MA, Whitehouse T, Jumaa P, Bion JF. Central venous catheter-related bloodstream infections: improving post-insertion catheter care. Journal of Hospital Infection 2009;71(2):117-22.
44. Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. Journal of Pediatrics 1994;125(2):259-63.
45. Westergaard B, Classen V, Walther-Larsen S. Peripherally inserted central catheters in infants and children - Indications, techniques, complications and clinical recommendations. Acta Anaesthesiologica Scandinavica 2013;57(3):278-87.
46. Wielenga J, Hilberdink A, Van Den Hoogen A. A systematic literature review of dressing techniques for peripherally inserted central venous catheters (CVC) in neonatal intensive care units. Intensive Care Med 2013;39:S133.
47. Wilson D, Verklan MT, Kennedy KA. Randomized trial of percutaneous central venous lines versus peripheral intravenous lines. Journal of Perinatology 2007;27(2):92-6.
48. Wirtschafter DD, Padilla G, Suh O, Wan K, Trupp D, Fayard EE. Antibiotic use for presumed neonatally acquired infections far exceeds that for central line-associated blood stream infections: an exploratory critique. Journal of Perinatology 2011;31(8):514-8.
49. Afsar FS. Skin care for preterm and term neonates. Clinical and Experimental Dermatology 2009;34(8):855-8. [PUBMED: 19575734]
50. Arora RS, Roberts R, Eden TO, Pizer B. Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter-related infections in children with cancer. Cochrane Database of Systematic Reviews 2010, Issue 12. [DOI: 10.1002/14651858.CD007785.pub2]
51. Bashir MH, Olson LK, Walters SA. Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin. American Journal of Infection Control 2012;40(4):344-8.
52. Bizzarro MJ, Sabo B, Noonan M, Bonfiglio MP, Northrup V, Diefenbach K. A quality improvement initiative to reduce central line-associated bloodstream infections in a neonatal intensive care unit. Infection Control and Hospital Epidemiology 2010;31(3):241-8.
53. Brown E, Wenzel RP, Hendley JO. Exploration of the microbial anatomy of normal human skin by using plasmid profiles of coagulase-negative staphylococci: search for the reservoir of resident skin flora. Journal of Infectious Diseases 1989;160(4):644-50.
54. O'Grady N, Alexander M, Burns LA, Dellinger P, Garland J, Heard SO, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011. Centers for Disease Control and Prevention (CDC), Healthcare Infection Control Practices Advisory Committee (HICPAC) publications. http://www.cdc.gov/hicpac/pdf/guidelines/bsi-guidelines-2011.pdf (accessed 3 April 2014).
55. Central Line-Associated Bloodstream Infection (CLABSI) Event. Centers for Disease Control and Prevention (CDC), Device-associated module publication. http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf (accessed 12 April 2014).
56. Chien LY, Macnab Y, Aziz K, Andrews W, McMillan DD, Lee SK. Variations in central venous catheter-related infection risks among Canadian neonatal intensive care units. Pediatric Infectious Disease Journal 2002;21(6):505-11.
57. Cicalini S, Palmieri F, Petrosillo N. Clinical review: new technologies for prevention of intravascular catheter-related infections. Critical Care 2004;8(3):157-62.
58. Costello JM, Morrow DF, Graham DA, Potter-Bynoe G, Sandora T, Laussen PC. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008;121(5):915-23.
59. Couto RC, Pedrosa TM, Tofani Cde P, Pedroso ER. Risk factors for nosocomial infection in a neonatal intensive care unit. Infection Control and Hospital Epidemiology 2006;27(6):571-5.
60. Fisher D, Cochran KM, Provost LP, Patterson J, Bristol T, Metzguer K, et al. Reducing central line-associated bloodstream infections in North Carolina NICUs. Pediatrics 2013;132(6):e1664-71. [PUBMED: 24249819]
61. Foster J, Richards R, Showell M. Intravenous in-line filters for preventing morbidity and mortality in neonates. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD005248.pub2]
62. Gavin NC, Webster J, Chan RJ, Rickard CM. Frequency of dressing changes for central venous access devices on catheter-related infections. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD009213]
63. Ge X, Cavallazzi R, Li C, Pan SM, Wang YW, Wang F-L. Central venous access sites for the prevention of venous thrombosis, stenosis and infection. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2012, issue 3. [DOI: 10.1002/14651858.CD004084.pub3; CD004084]
64. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94. [PUBMED: 21195583]
65. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). Journal of Clinical Epidemiology 2011;64(4):407-15. [PUBMED: 21247734]
66. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. Journal of Clinical Epidemiology 2011;64(12):1283-93. [PUBMED: 21839614]
67. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence--inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294-302. [PUBMED: 21803546]
68. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence--indirectness. Journal of Clinical Epidemiology 2011;64(12):1303-10. [PUBMED: 21802903]
69. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
70. Jaggi N, Rodrigues C, Rosenthal VD, Todi SK, Shah S, Saini N, et al. Impact of an international nosocomial infection control consortium multidimensional approach on central line-associated bloodstream infection rates in adult intensive care units in eight cities in India. International Journal of Infectious Diseases 2013;17(12):e1218-24.
71. Jardine LA, Inglis GD, Davies MW. Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous catheters. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006179.pub2]
72. Kabra NS, Kumar M, Shah SS. Multiple versus single lumen umbilical venous catheters for newborn infants. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004498.pub2]
73. Karpanen TJ, Worthington T, Conway BR, Hilton AC, Elliott TS, Lambert PA. Permeation of chlorhexidine from alcoholic and aqueous solutions within excised human skin. Antimicrobial Agents and Chemotherapy 2009;53(4):1717-9.
74. Karpanen TJ, Casey AL, Conway BR, Lambert PA, Elliott TS. Antimicrobial activity of a chlorhexidine intravascular catheter site gel dressing. Journal of Antimicrobial Chemotherapy 2011;66(8):1777-84.
75. Lai NA, Lai NM, O'Riordan E, Chaiyakunapruk N, Taylor JE, Tan K. Skin antisepsis during catheter insertion for reducing central venous catheter related infections. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD010140]
76. Lai NM, Chaiyakunapruk N, Lai NA, O'Riordan E, Pau WS, Saint S. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD007878.pub2]
77. Leeming JP, Holland KT, Cunliffe WJ. The microbial ecology of pilosebaceous units isolated from human skin. Journal of General Microbiology 1984;130(4):803-7.
78. Linares J. Diagnosis of catheter-related bloodstream infection: conservative techniques. Clinical Infectious Diseases 2007; Vol. 44, issue 6:827-9. [PUBMED: 17304455]
79. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. The New England Journal of Medicine 1977;296(23):1305-9.
80. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clinical Microbiology Reviews 1999;12(1):147-79. [PUBMED: 9880479]
81. Olsen AL, Reinholdt J, Jensen AM, Andersen LP, Jensen ET. Nosocomial infection in a Danish Neonatal Intensive Care Unit: a prospective study. Acta Paediatrica 2009;98(8):1294-9.
82. Pagani JL, Eggimann P. Management of catheter-related infection. Expert Review of Anti-infective Therapy 2008;6(1):31-7.
83. Payne NR, Carpenter JH, Badger GJ, Horbar JD, Rogowski J. Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics 2004;114(2):348-55. [PUBMED: 15286215]
84. Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. Journal of Hospital Infection 2007;65(Suppl 1):S1-64.
85. Raad II, Hanna HA. Intravascular catheter-related infections: new horizons and recent advances. Archives of Internal Medicine 2002;162(8):871-8. [PUBMED: 11966337]
86. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
87. Rijnders BJ, Van Wijngaerden E, Peetermans WE. Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence?. Clinical Infectious Diseases 2002;35(9):1053-8.
88. Rosenthal VD, Duenas L, Sobreyra-Oropeza M, Ammar K, Navoa-Ng JA, de Casares AC, et al. Findings of the International Nosocomial Infection Control Consortium (INICC), part III: effectiveness of a multidimensional infection control approach to reduce central line-associated bloodstream infections in the neonatal intensive care units of 4 developing countries. Infection Control and Hospital Epidemiology 2013;34(3):229-37.
89. Schoot RA, van Dalen EC, van Ommen CH, van de Wetering MD. Antibiotic and other lock treatments for tunnelled central venous catheter related infections in children with cancer. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2011, issue 2. [DOI: 10.1002/14651858.CD008975; CD008975]
90. Schünemann H, Brozek J, Guyatt G, Oxman A, editors. Grade Working Group. GRADE handbook for grading quality of evidence and strength of recommendations. Available from www.guidelinedevelopment.org/handbook Updated October 2013.
91. Sengupta A, Lehmann C, Diener-West M, Perl TM, Milstone AM. Catheter duration and risk of CLA-BSI in neonates with PICCs. Pediatrics 2010;125(4):648-53. [PUBMED: 20231192]
92. Shah PS, Shah N. Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD005983.pub2]
93. Taylor JE, Tan K, Lai NM, McDonald SJ. Antibiotic lock for the prevention of catheter-related sepsis in neonates. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD010336]
94. Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, et al. Dressings and securement devices for central venous catheters (CVC). Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD010367]
95. Vasudevan C, McGuire W. Early removal versus expectant management of central venous catheters in neonates with bloodstream infection. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD008436.pub2]
96. Washington K. The Bayley Scales of Infant Development-II and children with developmental delays: a clinical perspective. Journal of Developmental and Behavioral Pediatrics 1998;19(5):346-9.
97. Webster J, Gillies D, O'Riordan E, Sherriff KL, Rickard CM. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD003827.pub2]
98. Wong J, Dow K, Shah PS, Andrews W, Lee S. Percutaneously placed central venous catheter-related sepsis in Canadian neonatal intensive care units. American Journal of Perinatology 2012;29(8):629-34.
99. Worthington T, Elliott TS. Diagnosis of central venous catheter related infection in adult patients. Journal of Infection 2005;51(4):267-80.
100. Ygberg S, Nilsson A. The developing immune system - from foetus to toddler. Acta Paediatrica 2012;101(2):120-7.